“The biotech market in South Africa is projected to reach US$21.6 billion by 2030, driven by startups and global partnerships.”
South Africa’s biotechnology industry is experiencing rapid growth, with projections estimating a market value of US$21.6 billion by 2030. This expansion is fueled by startups such as BioCertica, Biovac, and Afrigen Biologics, alongside global partnerships and acquisitions like Roche’s purchase of Kapa Biosystems.
Investment funds such as BioVentures and OneBio Seed Investment Fund are nurturing biotech startups, providing capital and incubation support. These initiatives are fostering innovation in DNA sequencing, plant-based protein production, and vaccine development.
The industry’s growth is also supported by government policies promoting biotech research and commercialization. With a compound annual growth rate of 13.6%, South Africa is positioning itself as a leader in biotechnology across Africa.
This growth has implications for healthcare, agriculture, and industrial biotechnology, offering solutions to pressing challenges such as food security, disease management, and sustainable production.
